We urge FDA to reconsider on behalf of those facing Galactosemia, their family members & future generations.

FDA rejected Applied Therapeutics' Govorestat for galactosemia, citing NDA deficiencies. The company plans discussions for ...

Comparison of Hagar (representing flesh) and Sarah (representing the spirit); liberty of the Gospel; fruit of the Spirit. But God forbid that I should glory, save in the cross of our Lord Jesus Christ ...

Uniting our strengths in cell biology, molecular biology, physiology, and pathology, producing a genuinely translational approach to medicine. The Division of Digestive Diseases aims to change ...

NYU Grossman School of Medicine is a founding member of the Consortium of Accelerated Medical Pathway Programs (CAMPP). Formed in 2015 with eight medical schools and funded by the Josiah Macy Jr.

本文综合自：Cheng Li, Yaru Li. et al, Comprehensive modulatory effects of whole grain consumption on immune-mediated inflammation ...

Mouse embryonic fibroblasts (MEFs) were cultured in glucose-deficient or galactose medium to rely on OXPHOS for ATP production. [U-13 C] glutamine tracing was employed to study metabolic pathways ...

Govorestat is a central nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) being developed for the treatment of multiple rare diseases including Classic Galactosemia, Sorbitol ...

Metabolism is the process by which your body turns food into energy through chemical reactions in your cells. Your metabolic rate is a measurement of how many calories (units of energy) your body ...

A new report from the Los Angeles Regional Consortium (LARC) and the Career Ladders Project (CLP) details one initiative to building and scaling dual-enrollment pathways and the elements of a ...